PCM
USNA icon

Penserra Capital Management’s Usana Health Sciences USNA Stock Holding History

Penserra Capital Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-276
Closed -$19K – 1216
2022
Q2 		$19K Buy
276
+144
+109% +$10.7K ﹤0.01% 1122
2022
Q1 		$10K Hold
132
– – ﹤0.01% 1409
2021
Q4 		$13K Sell
132
-26
-16% -$2.59K ﹤0.01% 1277
2021
Q3 		$14K Hold
158
– – ﹤0.01% 1304
2021
Q2 		$16K Buy
+158
New +$15.9K ﹤0.01% 1209

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Penserra Capital Management's USNA Position: Q3 2022 in Review

Penserra Capital Management sold out of Usana Health Sciences (USNA) in Q3 2022, closing a stake of 276 shares — an estimated $19K sold.

Penserra Capital Management first reported a position in USNA in Q2 2021 and held it in 5 quarters. The position peaked at $19K in Q2 2022. 172 funds tracked by Wall St. Rank hold USNA as of Q3 2022.

  • Penserra Capital Management reported no remaining Usana Health Sciences position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 276 Usana Health Sciences shares in Q3 2022, an estimated $19K.
  • Penserra Capital Management first reported a position in Usana Health Sciences in Q2 2021 and held it in 5 quarters.
  • Penserra Capital Management's Usana Health Sciences position peaked at $19K in Q2 2022.
  • 172 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.